SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-165142
Filing Date
2020-06-10
Accepted
2020-06-10 07:41:55
Documents
3
Period of Report
2020-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d940780d8k.htm 8-K 20162
2 EX-99.1 d940780dex991.htm EX-99.1 11031
3 GRAPHIC g940780g37o09.jpg GRAPHIC 5281
  Complete submission text file 0001193125-20-165142.txt   39910
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 20953501
SIC: 2834 Pharmaceutical Preparations